Multiple myeloma: retrospective assessment of routine thromboprophylaxis and utility of thrombotic risk scores
Aspirin as primary thromboprophylaxis carries an unacceptable risk of VTE and bleeding in patients at intermediate or high thrombotic risk. The IMPEDE-VTE score performed best, although without reaching statistical significance. We confirm that VTE does not portend poor overall survival in MM.
Authors
- Omar Eduardo Fernandez Vargas (ORCID: https://orcid.org/0000-0001-8354-3374)
- Gabriela Cesarman‐Maus (ORCID: https://orcid.org/0000-0002-8397-0330)
- Isabel Amezcua
- Andrea Quintana Martinez
- Ramiro Espinoza
- Beatriz Cabello
Institutions
- Instituto Nacional de Cancerología (MX)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1016/j.rpth.2024.102571
- Citations
- 4
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.82